Sawgrass Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-574
Closed -$223K 191
2025
Q2
$223K Sell
574
-2
-0.3% -$804 0.03% 168
2025
Q1
$251K Sell
576
-18
-3% -$7.23K 0.03% 155
2024
Q4
$219K Sell
594
-28
-5% -$11.7K 0.02% 162
2024
Q3
$323K Sell
622
-1
-0.2% -$534 0.03% 148
2024
Q2
$338K Sell
623
-188
-23% -$99.4K 0.04% 147
2024
Q1
$421K Sell
811
-5
-0.6% -$2.49K 0.05% 142
2023
Q4
$385K Buy
+816
New +$377K 0.04% 147

Other funds holding ELV

Sawgrass Asset Management's ELV Position: Q3 2025 in Review

Sawgrass Asset Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 574 shares — an estimated $223K sold.

Sawgrass Asset Management first reported a position in ELV in Q4 2023 and held it in 7 quarters. The position peaked at $421K in Q1 2024. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Sawgrass Asset Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Sawgrass Asset Management sold 574 Elevance Health shares in Q3 2025, an estimated $223K.
  • Sawgrass Asset Management first reported a position in Elevance Health in Q4 2023 and held it in 7 quarters.
  • Sawgrass Asset Management's Elevance Health position peaked at $421K in Q1 2024.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Sawgrass Asset Management's 13F filing for Q3 2025, filed 31 Oct 2025.